Mathie Robert T, Baitson Elizabeth S, Frye Joyce, Nayak Chaturbhuja, Manchanda Rajkumar K, Fisher Peter
British Homeopathic Association, Hahnemann House, 29 Park Street West, Luton LU1 3BE, UK.
Homeopathy. 2013 Jul;102(3):187-92. doi: 10.1016/j.homp.2013.04.001.
We conducted a prospective, multi-centre, data collection survey of homeopathic practice in treatment of influenza-like illness in India during the 2009 pandemic of A/H1N1 influenza ('swine flu', SF).
To survey the practice of homeopathic practitioners in India in the management of SF, with respect to: (a) patients' symptoms at presentation and at follow-up (FU) consultation; (b) homeopathic medicines prescribed.
Data collection took place from October 2009 to February 2010, at the peak of the pandemic. All patients satisfying the minimum diagnostic symptoms of SF were eligible for inclusion. Data per appointment (in person or by telephone) were recorded by practitioners in spreadsheet format. All records were anonymised and included: whether patient was immunised against A/H1N1; influenza symptoms at consultation; the homeopathic medicine/s prescribed; whether antiviral medicine prescribed.
Twenty-three homeopathic physicians contributed to data collection. At the first appointment, 1126 patients had valid SF symptoms. A total of 89 different combinations of SF symptoms was observed, the most common being temperature >38°C + cough + runny nose (n = 170; 15.1%). A total of 44 different remedies (or combinations of remedies) were used at these first appointments, the most frequently prescribed being Arsenicum album (n = 265; 23.5%). For a total of 99 FU appointments with valid SF symptoms, Arsenicum album was prescribed most frequently overall (n = 28; 28.0%).
In our sample, the 2009 A/H1N1 influenza pandemic in India was characterised by several prominent symptoms and symptom/medicine associations, particularly temperature >38°C + cough + runny nose, associated with Arsenicum album. Future studies should collect additional keynote prescribing symptoms that influence the choice of homeopathic medicine.
我们开展了一项前瞻性、多中心的数据收集调查,以了解2009年甲型H1N1流感(“猪流感”,SF)大流行期间印度顺势疗法治疗流感样疾病的情况。
调查印度顺势疗法从业者对SF的治疗情况,涉及:(a)就诊时及随访(FU)咨询时患者的症状;(b)所开的顺势疗法药物。
数据收集于2009年10月至2010年2月大流行高峰期进行。所有符合SF最低诊断症状的患者均符合纳入条件。从业者以电子表格形式记录每次预约(当面或通过电话)的数据。所有记录均匿名,包括:患者是否接种了甲型H1N1疫苗;咨询时的流感症状;所开的顺势疗法药物;是否开了抗病毒药物。
23名顺势疗法医生参与了数据收集。首次预约时,1126名患者有有效的SF症状。共观察到89种不同的SF症状组合,最常见的是体温>38°C + 咳嗽 + 流鼻涕(n = 170;15.1%)。首次预约时共使用了44种不同的药物(或药物组合),最常开具的是白砷剂(n = 265;23.5%)。在总共99次有有效SF症状的FU预约中,总体上最常开具的是白砷剂(n = 28;28.0%)。
在我们的样本中,2009年印度甲型H1N1流感大流行的特点是有几种突出的症状以及症状/药物关联,特别是体温>38°C + 咳嗽 + 流鼻涕,与白砷剂有关。未来的研究应收集更多影响顺势疗法药物选择的主要开方症状。